Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MANP in Difficult to Control/Resistant Hypertension
NCT06343298Phase 2Recruiting
- Sponsor
- E-Star BioTech
- Start
- Nov 2024
- Primary completion
- Jul 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of M-atrial natriuretic peptide in resistant hypertension (RH), sponsored by E-Star BioTech. Started Nov 2024; status: recruiting.
02
Drugs
M-atrial natriuretic peptide
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT06343298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06343298.